Quidel Corporation - Asset Resilience Ratio
Quidel Corporation (QDEL) has an Asset Resilience Ratio of 0.56% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Quidel Corporation (QDEL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Quidel Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see QDEL current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Quidel Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Quidel Corporation (QDEL) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $32.40 Million | 0.56% |
| Total Liquid Assets | $32.40 Million | 0.56% |
Asset Resilience Insights
- Limited Liquidity: Quidel Corporation maintains only 0.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Quidel Corporation Industry Peers by Asset Resilience Ratio
Compare Quidel Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Quidel Corporation (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Quidel Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.56% | $32.40 Million | $5.77 Billion | -0.19pp |
| 2024-12-31 | 0.75% | $48.40 Million | $6.42 Billion | +0.19pp |
| 2023-12-31 | 0.57% | $48.40 Million | $8.56 Billion | -0.02pp |
| 2022-12-31 | 0.59% | $52.10 Million | $8.86 Billion | -0.47pp |
| 2021-12-31 | 1.06% | $25.70 Million | $2.43 Billion | -- |
| 2020-12-31 | 0.00% | $0.00 | $1.87 Billion | -- |
| 2017-12-31 | 0.00% | $0.00 | $935.25 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $388.25 Million | -- |
| 2015-12-31 | 0.02% | $63.00K | $406.50 Million | -0.68pp |
| 2014-12-31 | 0.70% | $3.13 Million | $447.41 Million | +0.34pp |
| 2013-12-31 | 0.36% | $969.00K | $271.49 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $242.10 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $278.89 Million | -- |
| 2009-12-31 | 2.40% | $4.00 Million | $166.34 Million | -- |
About Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more